Are your patients with diffuse large B-cell lymphoma
(DLBCL) eligible for a Phase III clinical trial?
(DLBCL) eligible for a Phase III clinical trial?
An investigational antibody-drug conjugate
for DLBCL
for DLBCL
Learn more about a Phase III clinical
trial in aggressive B-cell lymphoma
trial in aggressive B-cell lymphoma